Advanced Biomed Inc.
ADVB
$0.59
$0.1328.93%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.32% | -31.03% | -524.85% | 65.56% | 51.84% |
| Total Depreciation and Amortization | -58.15% | -5.90% | 35.01% | 14.45% | 402.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -100.00% |
| Change in Net Operating Assets | -604.90% | -2,176.84% | -131.04% | 112.56% | -88.32% |
| Cash from Operations | -224.51% | -219.94% | -2,554.23% | 95.20% | -373.29% |
| Capital Expenditure | 62.29% | -108.24% | 122.48% | -- | 74.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 62.29% | -108.24% | 122.48% | -- | 73.43% |
| Total Debt Issued | -55.81% | -50.25% | -39.40% | 30.68% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6,460.19% | 16,673.81% | 50.00% | -- | 84.57% |
| Cash from Financing | -336.63% | 949.27% | -38.87% | 25.32% | 159.70% |
| Foreign Exchange rate Adjustments | -67.02% | -89.09% | 193.10% | -212.14% | -77.34% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3,993.72% | 2,338.18% | -94.61% | 211.11% | -160.02% |